Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.
about
Comparison of real-time PCR and hemagglutination assay for quantitation of human polyomavirus JC.Monoclonal antibodies and progressive multifocal leukoencephalopathyThe changing landscape of progressive multifocal leukoencephalopathy.Detection of JC virus DNA fragments but not proteins in normal brain tissue.Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformationNeural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.Multiple roles for Puralpha in cellular and viral regulation.JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.Polyomavirus nephropathy in kidney transplantation.Human demyelinating disease and the polyomavirus JCV.Natalizumab and progressive multifocal leucoencephalopathy.Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.The role of polyomaviruses in human disease.Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.Progressive multifocal leucoencephalopathy in HIV/AIDS: observational study from a tertiary care centre in northern IndiaPotential mechanisms of the human polyomavirus JC in neural oncogenesisUpdate on progressive multifocal leukoencephalopathy.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.Modulation of JC virus transcription by C/EBPbetaCross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.Role of JC virus agnoprotein in DNA repair.The 50th birthday of progressive multifocal leukoencephalopathy: New insights into pathogenesis.Distribution of JC virus genotypes among Serbian patients infected with HIV and in healthy donors.Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.JC virus infection of the brain.JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.
P2860
Q25257331-FFF8D52D-EE41-4711-BB5F-E1F913318633Q28270413-4EDFB234-D49F-4C91-9F75-DF6037601BAEQ30403035-787FABED-4CE5-4F24-AE36-3F51165A77EFQ33358722-ACF65623-1097-4C5C-972A-0E744A393252Q34263748-C92FAF3D-FF7D-4B44-A4B3-2EA080CADC8DQ34714730-5161F8DA-FA70-48C5-A67C-26AD7AF653CAQ34785246-A39204F5-17E1-4F78-A189-02D7735A7117Q34934006-1570B02C-AB53-4135-B0BB-D37C74A10293Q35194420-FAFDE736-6648-4CCE-B2AE-5D7725519050Q35758657-6E649C51-E80E-468D-9DF2-7D115561FA32Q35841374-EF579C0F-31DA-4BD9-B02B-331808CB927DQ36455705-728F05DD-D3E0-4E16-9650-49FEA81392C2Q36622383-897A72FF-F24B-4095-946D-094FAA433896Q36672687-A1E8B5CA-E456-4A8E-9E11-56EDAD7060FCQ37141010-9482FA3D-0364-4CD2-B537-B2458C2B827BQ37141540-B39EC3E5-8545-45E8-BE02-F6B4A34B9342Q37156649-08DEB9AB-BB8A-4098-A599-5E73556D0343Q37224291-162D3ACD-C67B-4D9F-87A4-1E67EDE2D0FEQ38044681-E6B800F0-79F8-4DD9-92E2-4A0E38233D43Q38665891-1F4A0F36-3B5B-4A8A-B62F-E9C4A3BA9FF0Q39064776-31E33862-CA35-45F2-900E-6D5757A94572Q39615725-775CE974-C73E-40CC-B248-3056CA5C9518Q39800698-65824C07-7945-4AF5-BFAB-06880BD4931AQ40238292-795AB5CE-2824-4DE6-AD55-59C932C7AB9FQ40530783-80D486D6-7DA5-4C40-9D29-C29E6E41E200Q41124182-B98421FF-CCCE-4875-B914-AC6F3EC4D343Q42262662-D99B5C7D-71B6-4DD3-9990-89A90A632032Q42720362-A92B2883-A00B-4EF1-B8B1-CB113A6FF3E2Q45377474-96DE981F-4BD2-4896-9B81-EEB15ABDB50DQ45403289-953EDF86-CDBD-4817-965A-D8131AC44437Q47565422-6ADF811F-4761-40C6-A8EE-08A6BBB2FC71
P2860
Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Progressive multifocal leukoen ...... immunosuppressive conditions.
@ast
Progressive multifocal leukoen ...... immunosuppressive conditions.
@en
type
label
Progressive multifocal leukoen ...... immunosuppressive conditions.
@ast
Progressive multifocal leukoen ...... immunosuppressive conditions.
@en
prefLabel
Progressive multifocal leukoen ...... immunosuppressive conditions.
@ast
Progressive multifocal leukoen ...... immunosuppressive conditions.
@en
P1476
Progressive multifocal leukoen ...... immunosuppressive conditions.
@en
P2093
Joseph R Berger
P2888
P356
10.1080/13550280390195261
P478
P577
2003-01-01T00:00:00Z
P6179
1008689942